Endoscopy Operative Devices Market (2026 - 2033)

Endoscopy Operative Devices Market Summary

The global endoscopy operative devices market size was valued at USD 11.4 billion in 2025 and is projected to grow from USD 12.0 billion in 2026 to USD 17.2 billion in 2033, at a CAGR of 5.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% in 2025. The increasing prevalence of chronic diseases, particularly among the elderly population, is a major driver of market growth. Conditions such as gallstones, liver abscesses, pelvic abscesses, intestinal perforation, and endometriosis often require endoscopic intervention, resulting in a growing demand for endoscopy operative devices.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The shift to minimally invasive procedures is another key factor accelerating market growth. Endoscopic procedures offer numerous advantages, including reduced post-operative pain and complications, faster recovery, lighter anesthesia, and shorter hospital stays. This trend is expected to continue as patients and healthcare providers increasingly recognize the benefits of minimally invasive procedures. Technological advancements in endoscopic imaging and visualization systems are enhancing procedural precision, improving diagnostic accuracy, and enabling more effective therapeutic interventions. For instance, in October 2025, Fujifilm announced the launch of its next-generation ELUXEO 8000 Endoscopic Imaging System, featuring 4K resolution, enhanced LED multi-light technology, and a new Amber Red Color Imaging (ACI) mode to improve visualization during diagnostic and therapeutic endoscopic procedures. This launch reflects the industry's continued focus on advancing endoscopic technologies that enhance clinical outcomes, improve procedural efficiency, and support the growing adoption of minimally invasive surgery.

Favorable demographic trends in the global population are also contributing to market growth. According to the UN, by 2050, the global population aged 60 and above is projected to double, representing approximately 22.0% of the total population. This demographic shift is expected to drive demand for endoscopic procedures as the elderly population is more prone to chronic diseases requiring endoscopic intervention. Furthermore, growing awareness of the benefits of minimally invasive procedures is driving the rising demand for endoscopy.

The increasing demand for gastrointestinal endoscopy is also expected to drive market growth. This trend is driven by the rising prevalence of gastrointestinal disorders globally. The growing number of healthcare centers and the upgrading of healthcare infrastructure in developed and emerging economies are also driving demand for endoscopes and operative devices. Moreover, manufacturers are increasingly integrating artificial intelligence into endoscopy platforms to improve lesion detection and clinical decision-making. For instance, in September 2025, Olympus announced the commercial launch of its OLYSENSE CAD/AI portfolio in the U.S. and Europe, introducing AI-powered computer-aided detection applications designed to support earlier detection of gastrointestinal lesions and enhance endoscopic care pathways. The launch reflects the growing integration of artificial intelligence into endoscopy platforms to improve clinical outcomes and accelerate the adoption of advanced endoscopic operating devices.

Analyst Perspective

The global endoscopy operative devices market is evolving toward technologically advanced, minimally invasive, and digitally integrated surgical solutions as healthcare providers increasingly focus on improving clinical outcomes, minimizing procedural complications, and reducing recovery times. Market growth is driven by the rising prevalence of gastrointestinal disorders and other chronic diseases, the expanding geriatric population, and the increasing demand for diagnostic and therapeutic endoscopic procedures. Continuous technological advancements, including high-definition imaging systems, AI-powered lesion detection, and disposable endoscopes, are enhancing procedural accuracy, workflow efficiency, and infection prevention while improving patient safety. However, the high cost of advanced endoscopic devices, stringent regulatory requirements, and the need for specialized training remain key challenges. Nevertheless, ongoing product innovation, strategic collaborations, and growing investments in endoscopy technologies are expected to accelerate market expansion and create significant growth opportunities over the forecast period.

Product Insights

The reusable operative devices segment held the largest market share of over 80.0% in 2025, driven by their cost-effectiveness, improved durability, and performance. Healthcare providers are drawn to this option because it enables better visualization and maneuverability during procedures and aligns with the growing demand for minimally invasive surgeries. The increasing geriatric population and associated chronic diseases are further driving demand for reusable operative devices. Furthermore, manufacturers are increasingly introducing advanced reusable endoscopy systems with enhanced imaging capabilities and ergonomic designs to improve procedural efficiency and long-term clinical value. For instance, in December 2025, Olympus Corporation announced the launch of its OES Elite Rigid Cystoscopes in Europe, the Middle East, and Africa (EMEA). The reusable endoscopic devices feature improved instrument passage and redesigned ergonomics to reduce procedural strain while supporting minimally invasive urological and endoscopic interventions. The launch highlights the industry's focus on durable and high-performance reusable endoscopic operative devices.

Disposable operative devices are projected to grow at the fastest CAGR over the forecast period, driven by concerns about infection control and cross-contamination risks associated with reusable devices. Advancements in technology have enabled the development of high-quality disposable endoscopes with comparable performance, while minimally invasive procedures also contribute to the segment’s growth. In addition, manufacturers are increasingly investing in single-use endoscopic solutions that enhance sterility and procedural efficiency while meeting infection prevention requirements. For instance, in October 2025, Olympus Corporation announced the launch of SecureFlex, a single-use fine-needle biopsy device for endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) in Europe and Japan. The launch reflects the industry's growing investment in single-use endoscopic devices that improve infection prevention, procedural efficiency, and workflow optimization while supporting high-quality diagnostic outcomes.

Regional Insights

North America endoscopy operative devices market dominated with a revenue share of approximately 40.0% in 2025. Market growth in the region is aided by its advanced healthcare infrastructure, widespread adoption of cutting-edge technologies, and high prevalence rates of gastrointestinal disorders and chronic diseases. The growing geriatric population and emphasis on minimally invasive surgeries, which offer reduced recovery times and lower complication rates, also contribute to the region’s market dominance. Furthermore, manufacturers in the region continue to introduce advanced surgical technologies to enhance procedural precision and efficiency.

To learn more about this report, Download Free Sample Report

U.S. Endoscopy Operative Devices Market Trends

The U.S. dominated the North America endoscopy operative devices market with a share of around 90.0% in 2025. Market growth in the country is driven by the increasing preference for minimally invasive procedures, which offer benefits such as reduced postoperative pain and shorter recovery times. Advancements in endoscopic technology, high healthcare expenditure, and the presence of key manufacturers such as Olympus and Boston Scientific contribute to the market’s growth.

Europe Endoscopy Operative Devices Market Trends

The endoscopy operative devices market in Europe is anticipated to grow lucratively over the forecast period, owing to its advanced healthcare infrastructure, strong regulatory framework, and growing demand for minimally invasive surgeries. The increasing prevalence of chronic diseases and an aging population, particularly vulnerable to age-related ailments, fuel demand. Technological advancements in imaging and device design also contribute to growth. The growing demand for minimally invasive bariatric and gastrointestinal treatments is further encouraging manufacturers to develop innovative endoscopic therapeutic solutions. For instance, in June 2026, Ovesco Endoscopy AG announced that its BARS (Bariatric Anastomosis Reduction System) achieved more than 10% total body weight loss through endoscopic gastrojejunal anastomosis reduction procedures in patients following Roux-en-Y gastric bypass surgery. This development highlights the increasing demand for advanced therapeutic endoscopic devices that enable effective, minimally invasive treatment of obesity-related conditions while reducing the need for more invasive surgical revision procedures, thereby supporting the expansion of the endoscopy operative devices market across Europe.

Germany endoscopy operative devices market is driven by its focus on technological innovation and medical device advancements, resulting in sophisticated endoscopic solutions. The growing prevalence of chronic diseases, particularly gastrointestinal disorders, requires more endoscopic procedures. The benefits of minimally invasive surgeries, such as reduced recovery times, drive demand. Germany’s robust healthcare infrastructure and high expenditure support market growth.

Asia Pacific Endoscopy Operative Devices Market Trends

The endoscopy operative devices market in Asia Pacific is expected to register the fastest growth between 2026 and 2033. Factors such as increasing disposable incomes, improved healthcare infrastructure, and advanced endoscopic techniques are contributing to industry growth in the region. Global players are expanding their presence through distribution agreements and local manufacturing facilities. In addition, digitalization of endoscopy workflows and increasing investments in gastrointestinal care infrastructure are further accelerating market growth across the region.

Japan endoscopy operative devices market is driven by its aging population, with a high proportion of elderly individuals, leading to a rising demand for age-related disease treatment. The country’s technological innovation and emphasis on regulatory quality and safety standards ensure the production of high-quality devices. The adoption of minimally invasive surgeries and robust healthcare infrastructure further boosts market growth.

Key Endoscopy Operative Devices Companies Insights

Some key companies in the endoscopy operative devices market include Cook, Medtronic, CONMED Corporation, Boston Scientific Corporation, and Medical Device Business Services, Inc., among others. Manufacturers are adopting strategies such as technological collaborations, acquisitions, and expanded product portfolios to enhance their market position.

Key Endoscopy Operative Devices Companies

The following key companies have been profiled for this study on the endoscopy operative devices market:

• Cook

• Medtronic

• CONMED Corporation

• Boston Scientific Corporation

• Medical Device Business Services, Inc.

• Stryker

• KARL STORZ SE & Co. KG

• Richard Wolf GmbH

• FUJIFILM Corporation

• Olympus

• Smith+Nephew

• BD

Recent Developments

• In July 2024, Merit Medical Systems acquired EndoGastric Solutions’ EsophyX Z+ device for USD 105.00 million, expanding its endoscopy portfolio and enhancing its global footprint in the gastrointestinal market.

• In April 2024, Medtronic unveiled the future of AI in GI at the Genius Summit 2024, introducing ColonPRO software for the GI Genius intelligent endoscopy system and a strategic collaboration with ModMed to enhance patient care.

• In April 2024, KARL STORZ acquired the business of a distributor in Belgium, Luxembourg, and the Netherlands- Stöpler-expanding its direct sales presence in the region.

• In January 2024, Canon Medical Systems and Olympus announced a business alliance to develop and market Endoscopic Ultrasound Systems, combining Canon’s advanced diagnostic ultrasound technology with Olympus’ endoscope expertise.

Endoscopy Operative Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global endoscopy operative devices market report based on product and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Reusable Operative Devices
    • Energy Systems
    • Access Devices
    • Suction & Irrigation Systems
    • Hand Instruments
    • Wound Retractors
    • Snares
  • Disposable Operative Devices
    • Energy Systems
    • Access Devices
    • Suction & Irrigation Systems
    • Hand Instruments
    • Wound Retractors
    • Snares
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait